13 March 2024 | News
Integration of digitisation, computational biology, and automation harnesses the power of AI, computing, and automation
image credit- shutterstock
Sanyou Biopharmaceutical Co., contract research organisation based in China, has announced the official launch of the 'Sanyou Intelligent Innovative Biologics R&D Service Platform', representing a transformative advancement in biopharmaceutical research and development.
The platform encompasses ten meticulously designed systems aimed at optimising processes for customers. These include robust tools for managing customer projects, organising, and tracking samples, coordinating internal projects, and automating report generation.
Additionally, advanced capabilities for sequence analysis, primer design, experimental data processing, and drug development are integrated into the platform.
With sophisticated modeling and predictive drug resistance analysis functionalities, researchers can make informed decisions and accelerate innovation in biopharmaceuticals.
Furthermore, customer map management feature enables visualisation and analysis of customer data, facilitating strategic decision-making and customer relationship management. Together, these integrated systems empower researchers to streamline workflows, enhance productivity, and deliver impactful solutions.